Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Alì

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 18, 2020
Salvage radiotherapy in patients affected by oligorecurrent pelvic nodal prostate cancerG Ingrosso, C Mariucci, M V Tenti, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 14, 2025
Low-Dose Radiotherapy for Primary Cutaneous Indolent B-Cell Lymphomas: a Multicenter Retrospective StudyE Alì, G Simontacchi, M Levis, et al.
Lung Cancer (Amsterdam, Netherlands)|August 28, 2025
Locally advanced NSCLC: overview of real-world pattern of recurrence in durvalumab era (LEOPARD trial)P Ciammella, F Iori, P Borghetti, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 18, 2020
Salvage radiotherapy in patients affected by oligorecurrent pelvic nodal prostate cancerG Ingrosso, C Mariucci, M V Tenti, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 14, 2025
Low-Dose Radiotherapy for Primary Cutaneous Indolent B-Cell Lymphomas: a Multicenter Retrospective StudyE Alì, G Simontacchi, M Levis, et al.
Lung Cancer (Amsterdam, Netherlands)|August 28, 2025
Locally advanced NSCLC: overview of real-world pattern of recurrence in durvalumab era (LEOPARD trial)P Ciammella, F Iori, P Borghetti, et al.
Pageof 1